South Africa now appears to have made a massive error in not rolling out AstraZeneca, while in the UK a study suggests a mix of vaccines may be the way forward.
New research has shown that the impact of COVID in Greater Manchester is linked to socio-economic deprivation. The authors say their findings are replicable across the UK.
The strong disapproval of the South African government’s handling of the pandemic is a warning that crafting persuasive pro-vaccine messages is not enough.
Relying on donor funding means that the funder ultimately determines the health priorities. This is one reason why many programmes in Africa focus on a single disease such as HIV.
Data from the UK, where the Delta variant is dominant, suggest many people with COVID-19 are experiencing cold-like symptoms such as a runny nose and a sore throat.
With enough vaccine supplies coming online from October, the government has no excuse not to have all arrangements in place for an efficient vaccination program. Here’s what needs to change.
At the height of polio and H1N1, Canadians were keen to get vaccinated, but vaccine enthusiasm waned once the crisis had passed — what does that mean for COVID-19?
When a crisis like COVID-19 disrupts expectations for the future, it also disrupts how health messaging works. Advertising research shows three ways that health campaigns can succeed in a crisis.
Should people be compelled to take the vaccine? Should you feel guilty for skipping the line? And what about parts of the world where vaccines aren’t readably available? Ethicists have it covered.
Nicholas Steyn, University of Auckland, Waipapa Taumata Rau; Michael Plank, University of Canterbury, dan Shaun Hendy, University of Auckland, Waipapa Taumata Rau
New Zealand will have to vaccinate 80-85% to reach population immunity. Until then, a blanket border re-opening, even if only for vaccinated people, would pose a high risk of new outbreaks.
Pressure is mounting to reopen the Canada-U.S. border, but there are risks. How well those risks are managed may be the difference between pandemic recovery or a fourth wave of COVID-19.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand